Business Segments · Goodwill
Biopharma Laboratory Services — Goodwill
Labcorp Holdings Biopharma Laboratory Services — Goodwill decreased by 0.7% to $1.35B in Q1 2026 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2022
Last reportedQ1 2026
Rolls up toGoodwill
How to read this metric
A decrease often signals impairment charges, while stability or growth reflects historical acquisition activity and valuation.
Detailed definition
This represents the intangible asset value recorded when the Biopharma Laboratory Services segment acquires other busine...
Peer comparison
Standard balance sheet item for companies that grow through M&A.
Metric ID:
lh_segment_biopharma_laboratory_services_goodwillHistorical Data
7 periods
| Q4 '22 | Q4 '23 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $1.59B | $1.33B | $1.27B | $1.39B | $1.35B | $1.35B | $1.35B |
| QoQ Change | — | -16.5% | -4.6% | +9.3% | -2.5% | +0.3% | -0.7% |
| YoY Change | — | -16.5% | -4.6% | — | — | +6.9% | — |
Range$1.27B – $1.59B
CAGR-10.5%
Avg YoY Growth-4.7%
Median YoY Growth-4.6%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's biopharma laboratory services — goodwill?
- Labcorp Holdings (LH) reported biopharma laboratory services — goodwill of $1.35B in Q1 2026.
- What does biopharma laboratory services — goodwill mean?
- The total value of intangible assets recorded from past acquisitions within the Biopharma Laboratory Services segment.